Global Riboflavin Kinase Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Riboflavin Kinase market size was valued at US$ 822 million in 2024 and is forecast to a readjusted size of USD 1259 million by 2031 with a CAGR of 6.3% during review period.
Riboflavin Kinase is a vitamin that is needed for growth and overall good health. It helps the body break down carbohydrates, proteins and fats to produce energy, and it allows oxygen to be used by the body. In enzymology, Riboflavin Kinase is an enzyme that works as catalysis for ATP. Riboflavin is known as Vitamin B2 and is converted into flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) by riboflavin kinase and FMN adenylyltransferase, respectively.
According to our Wellness & Health Research Center, the global wellness & health economy was valued at US dollars 4.8 trillion. Asia Pacific was the region with the highest spending on big health in 2022, with a total spending of $1.68 trillion, followed by North America ($1.42 trillion) and Europe ($1.0 trillion). According to the health industry accounting analysis data disclosed by the Health Development Research Center of the National Health Commission, from 2019 to 2021, the market size of the health service industry grew by an average of 7.0% per year, and the specific data increased from 7.7 trillion yuan to 8.8 trillion yuan. China"s health industry revenue reached 8.0 trillion yuan in 2021, with an increase of 8.1%.
This report is a detailed and comprehensive analysis for global Riboflavin Kinase market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Riboflavin Kinase market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Riboflavin Kinase market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Riboflavin Kinase market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Riboflavin Kinase market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Riboflavin Kinase
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Riboflavin Kinase market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include DSM, BASF, NB Group, Shanghai Acebright Pharmaceuticals, Hubei Guangji Pharmaceutical, Ningxia Qiyuan Pharma, Hebei Shengxue Dacheng, Xinfa Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Riboflavin Kinase market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Feed Grade
Food Grade
Pharma Grade
Market segment by Application
Food Additives
Animal Feeding
Pharmaceutical
Health Supplements
Cosmetic And Personal Care
Others
Major players covered
DSM
BASF
NB Group
Shanghai Acebright Pharmaceuticals
Hubei Guangji Pharmaceutical
Ningxia Qiyuan Pharma
Hebei Shengxue Dacheng
Xinfa Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Riboflavin Kinase product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Riboflavin Kinase, with price, sales quantity, revenue, and global market share of Riboflavin Kinase from 2020 to 2025.
Chapter 3, the Riboflavin Kinase competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Riboflavin Kinase breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Riboflavin Kinase market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Riboflavin Kinase.
Chapter 14 and 15, to describe Riboflavin Kinase sales channel, distributors, customers, research findings and conclusion.
Riboflavin Kinase is a vitamin that is needed for growth and overall good health. It helps the body break down carbohydrates, proteins and fats to produce energy, and it allows oxygen to be used by the body. In enzymology, Riboflavin Kinase is an enzyme that works as catalysis for ATP. Riboflavin is known as Vitamin B2 and is converted into flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) by riboflavin kinase and FMN adenylyltransferase, respectively.
According to our Wellness & Health Research Center, the global wellness & health economy was valued at US dollars 4.8 trillion. Asia Pacific was the region with the highest spending on big health in 2022, with a total spending of $1.68 trillion, followed by North America ($1.42 trillion) and Europe ($1.0 trillion). According to the health industry accounting analysis data disclosed by the Health Development Research Center of the National Health Commission, from 2019 to 2021, the market size of the health service industry grew by an average of 7.0% per year, and the specific data increased from 7.7 trillion yuan to 8.8 trillion yuan. China"s health industry revenue reached 8.0 trillion yuan in 2021, with an increase of 8.1%.
This report is a detailed and comprehensive analysis for global Riboflavin Kinase market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Riboflavin Kinase market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Riboflavin Kinase market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Riboflavin Kinase market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2020-2031
Global Riboflavin Kinase market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Riboflavin Kinase
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Riboflavin Kinase market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include DSM, BASF, NB Group, Shanghai Acebright Pharmaceuticals, Hubei Guangji Pharmaceutical, Ningxia Qiyuan Pharma, Hebei Shengxue Dacheng, Xinfa Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Riboflavin Kinase market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Feed Grade
Food Grade
Pharma Grade
Market segment by Application
Food Additives
Animal Feeding
Pharmaceutical
Health Supplements
Cosmetic And Personal Care
Others
Major players covered
DSM
BASF
NB Group
Shanghai Acebright Pharmaceuticals
Hubei Guangji Pharmaceutical
Ningxia Qiyuan Pharma
Hebei Shengxue Dacheng
Xinfa Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Riboflavin Kinase product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Riboflavin Kinase, with price, sales quantity, revenue, and global market share of Riboflavin Kinase from 2020 to 2025.
Chapter 3, the Riboflavin Kinase competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Riboflavin Kinase breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Riboflavin Kinase market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Riboflavin Kinase.
Chapter 14 and 15, to describe Riboflavin Kinase sales channel, distributors, customers, research findings and conclusion.
Table of Contents
93 Pages
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
